Jason Kwah, MD, MSc

2026

• Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study

  Lommatzsch M, Schmidt O, Timmermann H, Gappa M, Watz H, Kwah J, Ledanois O, Nischan N, Hahn M, Heimann A, Korn S. Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study. Respiratory Medicine 2026, 254: 108750. PMID: 41785977, DOI: 10.1016/j.rmed.2026.108750.

  Peer-Reviewed Original Research

  MeSH Keywords and Concepts

• Validity of PEN-FAST as a clinical decision tool in pregnant patients

  You L, Belmont A, Liao J, Su C, Trubiano J, Son M, Burn M, Kwah J. Validity of PEN-FAST as a clinical decision tool in pregnant patients. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100671. PMID: 41852857, PMCID: PMC12993893, DOI: 10.1016/j.jacig.2026.100671.

  Peer-Reviewed Original Research

  Concepts

• Penicillin allergy testing among patients evaluated in allergy clinic: An observational study assessing clinical and social determinants associated with completion of testing

  Novotny S, Workineh A, Elmansy L, Kwah J, Liao J, Wong K, Stone C, Belmont A. Penicillin allergy testing among patients evaluated in allergy clinic: An observational study assessing clinical and social determinants associated with completion of testing. The Journal Of Allergy And Clinical Immunology 2026, 157: ab112. DOI: 10.1016/j.jaci.2025.12.332.

  Peer-Reviewed Original Research

  Concepts

• Assessing the Validity of the Electronic Medical Record Allergy Section and ICD Codes for Identification of Penicillin Allergy Labels

  Elmansy L, Novotny S, Kwah J, Liao J, Wong K, Stone C, Belmont A. Assessing the Validity of the Electronic Medical Record Allergy Section and ICD Codes for Identification of Penicillin Allergy Labels. The Journal Of Allergy And Clinical Immunology 2026, 157: ab100. DOI: 10.1016/j.jaci.2025.12.294.

  Peer-Reviewed Original Research

  Concepts

• Systemic Corticosteroid Use Before Biologic Initiation Among Pediatric Patients With Asthma in the United States

  Guilbert T, Anderson W, Song X, Chen C, Noshad S, Gandhi A, Avella H, Kwah J, Ge W, Jackson D. Systemic Corticosteroid Use Before Biologic Initiation Among Pediatric Patients With Asthma in the United States. The Journal Of Allergy And Clinical Immunology 2026, 157: ab48. DOI: 10.1016/j.jaci.2025.12.144.

  Peer-Reviewed Original Research

  Concepts

• Systemic Corticosteroid Use Among Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma in the United States

  Jackson D, Noshad S, Song X, Chen C, Gandhi A, Avella H, Kwah J, Ge W, Guilbert T. Systemic Corticosteroid Use Among Pediatric Patients With Uncontrolled Moderate-to-Severe Asthma in the United States. The Journal Of Allergy And Clinical Immunology 2026, 157: ab41. DOI: 10.1016/j.jaci.2025.12.125.

  Peer-Reviewed Original Research

  Concepts

• Real-World Outcomes Following Asthma Treatment Escalation From Medium-Dose ICS to high-Dose ICS or Biologics

  Lugogo N, Katial R, Petruski-Ivleva N, Avella H, Moraco A, Yang J, Kwah J, Rondeau F, Taiji R, Vekeman F, Gandhi A. Real-World Outcomes Following Asthma Treatment Escalation From Medium-Dose ICS to high-Dose ICS or Biologics. The Journal Of Allergy And Clinical Immunology 2026, 157: ab46. DOI: 10.1016/j.jaci.2025.12.139.

  Peer-Reviewed Original Research

  Concepts

• Escalation To High-Dose ICS Versus Dupilumab Initiation in Uncontrolled Asthma Patients on Medium-Dose ICS: A Matched Analysis of Administrative Claims

  Katial R, Lugogo N, Petruski-Ivleva N, Avella H, Ledanois O, Kwah J, Yang J, Rondeau F, Taiji R, Vekeman F, Gandhi A. Escalation To High-Dose ICS Versus Dupilumab Initiation in Uncontrolled Asthma Patients on Medium-Dose ICS: A Matched Analysis of Administrative Claims. The Journal Of Allergy And Clinical Immunology 2026, 157: ab43. DOI: 10.1016/j.jaci.2025.12.131.

  Peer-Reviewed Original Research

  Concepts

• Patient-Reported Burden Of Coexisting Type 2 Inflammatory Conditions In Patients Initiating Dupilumab For Asthma: Baseline Data From The REVEAL Registry

  Maspero J, Al-Ahmad M, Arnaout R, Belevskiy A, Vargas-Ramírez L, Mobayed H, Mahboub B, Irani C, Bar-Shai A, Koh M, Chao J, Zaghloul S, Kwah J, Dewhurst J. Patient-Reported Burden Of Coexisting Type 2 Inflammatory Conditions In Patients Initiating Dupilumab For Asthma: Baseline Data From The REVEAL Registry. The Journal Of Allergy And Clinical Immunology 2026, 157: ab214. DOI: 10.1016/j.jaci.2025.12.640.

  Peer-Reviewed Original Research

  Concepts

• Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study

  Bourdin A, Canonica G, Virchow J, Borsos K, Stanford R, Ledanois O, Kwah J, Ge W, Huynh L, Duh M, Boca A, Cheng W, Gandhi A. Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. Respiratory Research 2026, 27: 67. PMID: 41639827, PMCID: PMC12903220, DOI: 10.1186/s12931-026-03515-7.

  Peer-Reviewed Original Research

  Concepts